Utter Therapeutics Inc.
- UEI
- XUKAM8HMLC71
- CAGE
- 9MSP0
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Website
- uttertherapeutics.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Phase i therapeutic award - developing split, conditionally active peptidomimetics of IL-12 for the treatment of rare… | National Cancer Institute | $299,500 |
Quick answers
What is Utter Therapeutics Inc.'s UEI?
Utter Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is XUKAM8HMLC71.
What is Utter Therapeutics Inc.'s CAGE code?
Utter Therapeutics Inc.'s CAGE code is 9MSP0.
What is Utter Therapeutics Inc.'s primary NAICS code?
Utter Therapeutics Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Is Utter Therapeutics Inc. registered in SAM.gov?
Utter Therapeutics Inc.'s SAM.gov registration expired on July 10, 2025.
What is Utter Therapeutics Inc.'s most recent federal award?
Utter Therapeutics Inc.'s most recent federal contract award is Phase i therapeutic award - developing split, conditionally active peptidomimetics of IL-12 for the treatment of rare… (75N91024C00004), from National Cancer Institute, on February 15, 2024.
On GovTribe
See Utter Therapeutics Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors